Alcatel is one of
the few Chinese companies present in the United States, and it's also
one of the few that has partnerships with US carriers.
The latest device launched by Alcatel in the United
States is called Pop 7 LTE, which is a small tablet that provides the
usual Android experience. It's not a high-end device, but it offers
decent specs for a low price.
According to
Alcatel,
the Pop 7 LTE is now available for purchase at T-Mobile for just $130.
Obviously, customers won't have to sign up for a long-term agreement
since the Magenta carrier dropped contracts quite a while ago.
But the low price is not the only thing worth
mentioning, as Alcatel has decided to include Android 6.0 Marshmallow
operating system with the Pop 7 LTE, which is quite rare for such cheap
tablets.
The rest of the slate's specs aren't impressive at
all. As the name suggests, the tablet sports a 7-inch capacitive
touchscreen display that supports HD (1024 x 600 pixels) resolution and
features oleophobic coating.
Unimpressive specs inside, but Marshmallow is a plus
Hardware-wise, Alcatel Pop 7 LTE comes equipped with
a 1.1GHz quad-core Qualcomm Snapdragon 210 processor, coupled with 1GB
of RAM and 8GB of internal memory, which can be expanded up to 32GB via
microSD card slot.
At the back, there's a 5-megapixel photo snapper
with fixed focus and video recording, while in the front there's a
secondary 2-megapixel camera for selfies.
Alcatel's entry-level tablet supports 4G LTE Cat 4
and drains energy from a decent 3,240 mAh battery, which hasn't been
rated by the manufacturer yet.
“Our connected devices are more than just tools for
keeping us in touch, they’re also our access to the entertainment and
content we love. With the POP 7 LTE, T-Mobile customers are getting a
value-packed tablet that delivers just that and more; delivering an easy
to use and customizable pure Android experience along with great
performance for being connected on the go,” said Jon Maron, vice
president of Marketing and Communications for Alcatel, North America.
Comments
Post a Comment